Bumper Offer - Urjas oil Just @ Rs. 1
Tacrozer is a commercial drug that is prescribed in the form of Ointment. It is typically used for the treatment of Liver transplant, Kidney transplant, Heart Transplant. The alternative uses of Tacrozer have also been explained below.
The right dosage of Tacrozer depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Tacrozer side effects, there are can be others also. These have been listed below. These side effects of Tacrozer are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Tacrozer's effect is Moderate during pregnancy and Moderate for lactating mothers. It is important to know if Tacrozer has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Tacrozer related warnings section.
Tacrozer is contraindicated in people with pre-existing medical conditions like Infections, Diabetes Type 2 as it can result in adverse effects. Other contraindications of Tacrozer have been discussed in the sections ahead.
Besides this, Tacrozer may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Tacrozer is safe while driving, and is addiction.
Tacrozer is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Tacrozer is used -
Moderate
Mild
Is the use of Tacrozer safe for pregnant women?
Tacrozer can have harmful effects in pregnant women. If you experience any discomfort after using Tacrozer, then discontinue the use and take your doctor's advice.
Is the use of Tacrozer safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Tacrozer. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Tacrozer on the Kidneys?
There can be some harmful effects on your kidneys after taking Tacrozer. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Tacrozer on the Liver?
Tacrozer can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Tacrozer on the Heart?
Tacrozer may have severe effects on your heart, so do not take it without first consulting your doctor.
Tacrozer should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tacrozer unless your doctor advises you to do so -
Is this Tacrozer habit forming or addictive?
No, there is no any evidence that Tacrozer is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Tacrozer will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but consume Tacrozer only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Tacrozer for mental disorders.
Interaction between Food and Tacrozer
Information is not available on the interaction of any foods with Tacrozer, due to a lack of research on this.
Interaction between Alcohol and Tacrozer
Consult your doctor before consuming alcohol while taking Tacrozer as it can have severe side effects.
No, you cannot take the Tacrozer with fluconazole, as it may change the effect of the Tacrozer and cause some serious side effects, always consult your doctor before taking this drug combination.
Tacrozer is a brand name of tacrolimus and it is available in the form of a capsule, granules for oral suspension, an extended-release tablet, injectables, and ointment. It belongs to the class of drugs known as immunosuppressants. Tacrozer is a prescription drug that is used to prevent the rejection of organ transplants (liver and kidney). The topical form of Tacrozer is used to treat eczema.
No, you cannot take the Tacrozer with clarithromycin, as it may change the effect of the Tacrozer and cause some serious side effects, always consult your doctor before taking this drug combination.
Yes, Tacrozer may cause a headache. It has been reported by the patients who are taking this drug. If you are experiencing the same after taking this drug, you are advised to consult about it with your doctor.
Yes, Tacrozer may cause swelling of the arms, hands, feet, ankles, or lower legs. It is one of the serious side effects of this drug. If you are experiencing the same after taking this drug, you are advised to consult about it with your doctor immediately.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
